thiazoles has been researched along with Cystic Fibrosis in 35 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (2.86) | 18.7374 |
1990's | 3 (8.57) | 18.2507 |
2000's | 6 (17.14) | 29.6817 |
2010's | 21 (60.00) | 24.3611 |
2020's | 4 (11.43) | 2.80 |
Authors | Studies |
---|---|
Baroni, D; Brandas, C; Cichero, E; Ludovico, A; Millo, E; Moran, O; Parodi, A | 1 |
Amico, G; Baroni, D; Brandas, C; Moran, O | 1 |
Cichero, E; Damonte, G; Liessi, N; Millo, E; Pedemonte, N; Pesce, E; Salis, A; Tasso, B | 1 |
Leoni, A; Locatelli, A; Morigi, R; Pedemonte, N; Pesce, E | 1 |
Barraja, P; Barreca, M; Cilibrasi, V; Galietta, LJV; Genovese, M; Montalbano, A; Renda, M; Spanò, V | 1 |
Arkel, M; Cichero, E; Damonte, G; Fossa, P; Galietta, LJV; Liessi, N; Millo, E; Paccagnella, M; Pedemonte, N; Pesce, E; Salis, A; Tasso, B; Tomati, V | 1 |
Bugatti, A; Cichero, E; D'Ursi, P; Di Somma, M; Fossa, P; Galietta, LJV; Milanesi, L; Millo, E; Orro, A; Rusnati, M; Sala, D; Trombetti, G; Urbinati, C | 1 |
Bear, CE; Casavola, V; Laselva, O; Molinski, S | 1 |
Barraja, P; Carbone, A; Galietta, LJV; Montalbano, A; Scudieri, P; Spanò, V | 1 |
Bartlett, MC; Clarke, DM; Loo, TW | 1 |
El-Badri, F; Hu, B; Hudson, BM; Kurth, MJ; Phuan, PW; Tantillo, DJ; Verkman, AS; Ye, L | 1 |
Anzaldi, M; Galietta, LJ; Mazzei, M; Mazzei, MT; Nieddu, E; Pedemonte, N; Pesce, E; Pollarolo, B; Schenone, S | 1 |
Bellotti, M; Cichero, E; Damonte, G; Fossa, P; Galatini, A; Galietta, LJ; Gianotti, A; Guariento, S; Liessi, N; Millo, E; Pedemonte, N; Pesce, E; Salis, A; Zegarra-Moran, O | 1 |
Beekman, JM; de Winter-de Groot, KM; Dekkers, JF; Gogorza Gondra, RA; Janssens, HM; Kruisselbrink, E; van der Ent, CK; Vonk, AM | 1 |
Bali, V; Bebok, Z; Guroji, P; Lazrak, A; Matalon, S | 1 |
Buzid, A; Glennon, JD; Hayes, PE; Luong, JH; McGlacken, GP; Muimhneacháin, EÓ; O'Gara, F; Pardo, LM; Reen, FJ; Shang, F; Sperry, J | 1 |
El-Idreesy, TT; Fettinger, JC; Kurth, MJ; Lodewyk, MW; Meng, L; Tantillo, DJ; Verkman, AS; Yang, B; Yoo, CL; Yu, GJ | 1 |
Cyr, DM; Grove, DE; Naren, AP; Ren, HY; Rosser, MF | 1 |
Butler, JD; Kurth, MJ; Mills, AD; Verkman, AS; Yang, B; Yoo, C | 1 |
Fettinger, JC; Knapp, JM; Kurth, MJ; Sangwung, P; Verkman, AS; Ye, L | 1 |
Armirotti, A; Caci, E; Damonte, G; Galietta, LJ; Millo, E; Pedemonte, N; Sondo, E; Tomati, V; Zegarra-Moran, O | 1 |
Caldwell, RA; Cyr, DM; Grove, DE; Houck, SA | 1 |
Lamont, IL; Martin, LW; Reid, DW; Sharples, KJ | 1 |
Caci, E; Esposito, AI; Galietta, LJ; Pedemonte, N; Pfeffer, U; Sondo, E; Tomati, V | 1 |
Davison, HR; Derichs, N; Drake, C; Jones, EF; Kurth, MJ; Phuan, PW; Sutcliffe, J; Taylor, S; Verkman, AS; Yao, C | 1 |
Codd, R; Cordwell, SJ; Harbour, C; Hare, NJ; Manos, J; Rose, B; Soe, CZ | 1 |
Donald, MB; Kurth, MJ; Phuan, PW; Rodriguez, KX; Shay, H; Verkman, AS | 1 |
Arányi, P; Bátori, S; Kapui, Z; Mikus, E; Nagy, LT; Urbán-Szabó, K; Varga, M; Vasvári-Debreczy, L | 1 |
Haggie, PM; Song, Y; Thiagarajah, JR; Verkman, AS | 1 |
Abraham, SN; Duncan, MJ; Li, G; Wright, JR; Zaas, DW | 1 |
Caci, E; Du, K; Galietta, LJ; Lukacs, GL; Pedemonte, N; Verkman, AS; Zegarra-Moran, O | 1 |
Axton, RA; Brock, DJ | 1 |
Chan, M; Cox, AD; Darling, P; Sokol, PA | 1 |
Castignetti, D; Haas, B; Murphy, E | 1 |
Sokol, PA | 1 |
1 review(s) available for thiazoles and Cystic Fibrosis
Article | Year |
---|---|
An overview on chemical structures as ΔF508-CFTR correctors.
Topics: Animals; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Humans; Mutation; Protein Folding; Pyrimidinones; Thiazoles | 2019 |
34 other study(ies) available for thiazoles and Cystic Fibrosis
Article | Year |
---|---|
NBD2 Is Required for the Rescue of Mutant F508del CFTR by a Thiazole-Based Molecule: A Class II Corrector for the Multi-Drug Therapy of Cystic Fibrosis.
Topics: Aminopyridines; Benzodioxoles; Cell Membrane; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Epithelial Cells; Gene Expression Regulation; HEK293 Cells; Humans; Mutant Proteins; Phenylalanine; Thiazoles | 2021 |
Unravelling the Regions of Mutant F508del-CFTR More Susceptible to the Action of Four Cystic Fibrosis Correctors.
Topics: Aminopyridines; Benzamides; Benzodioxoles; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Gene Expression Regulation; HEK293 Cells; Humans; Indoles; Mutant Proteins; Mutation; Quinazolines; Thiazoles | 2019 |
Synthesis and Structure-activity Relationship of Aminoarylthiazole Derivatives as Potential Potentiators of the Chloride Transport Defect in Cystic Fibrosis.
Topics: Biological Transport; Chemistry Techniques, Synthetic; Chlorides; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Drug Evaluation, Preclinical; Structure-Activity Relationship; Thiazoles | 2021 |
Synthesis and biological evaluation of thiazole derivatives on basic defects underlying cystic fibrosis.
Topics: Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Dose-Response Relationship, Drug; Humans; Molecular Structure; Structure-Activity Relationship; Thiazoles | 2020 |
Evaluation of Fused Pyrrolothiazole Systems as Correctors of Mutant CFTR Protein.
Topics: Aminoimidazole Carboxamide; Benzodioxoles; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Humans; Mutant Proteins; Mutation; Protein Folding; Thiazoles | 2021 |
Synthesis and biological evaluation of novel thiazole- VX-809 hybrid derivatives as F508del correctors by QSAR-based filtering tools.
Topics: Aminopyridines; Benzodioxoles; Cell Line; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Humans; Mutation; Quantitative Structure-Activity Relationship; Thiazoles | 2018 |
Speeding Up the Identification of Cystic Fibrosis Transmembrane Conductance Regulator-Targeted Drugs: An Approach Based on Bioinformatics Strategies and Surface Plasmon Resonance.
Topics: Binding Sites; Computational Biology; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Drug Evaluation, Preclinical; Humans; Molecular Dynamics Simulation; Protein Binding; Surface Plasmon Resonance; Thiazoles | 2018 |
Correctors of the Major Cystic Fibrosis Mutant Interact through Membrane-Spanning Domains.
Topics: Aminopyridines; Benzamides; Benzodioxoles; Cell Line; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; HEK293 Cells; Humans; Mutation; Phenylalanine; Protein Structure, Tertiary; Thiazoles | 2018 |
Bithiazole correctors rescue CFTR mutants by two different mechanisms.
Topics: Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Humans; Models, Molecular; Molecular Structure; Mutation; Protein Binding; Protein Structure, Tertiary; Thiazoles | 2013 |
ΔF508-CFTR correctors: synthesis and evaluation of thiazole-tethered imidazolones, oxazoles, oxadiazoles, and thiadiazoles.
Topics: Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Humans; Imidazoles; Kinetics; Molecular Conformation; Oxadiazoles; Oxazoles; Protein Binding; Structure-Activity Relationship; Thermodynamics; Thiadiazoles; Thiazoles; Water | 2014 |
The search for a common structural moiety among selected pharmacological correctors of the mutant CFTR chloride channel.
Topics: Anisoles; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Gene Deletion; Humans; Models, Molecular; Molecular Conformation; Piperazines; Purines; Pyrazines; Sildenafil Citrate; Sulfonamides; Thiazoles; Vasodilator Agents | 2014 |
Synthesis and structure-activity relationship of aminoarylthiazole derivatives as correctors of the chloride transport defect in cystic fibrosis.
Topics: Biological Transport; Cell Line; Chemistry Techniques, Synthetic; Chlorides; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Drug Design; Humans; Ion Channel Gating; Models, Molecular; Mutation; Protein Structure, Tertiary; Structure-Activity Relationship; Thiazoles | 2015 |
Optimal correction of distinct CFTR folding mutants in rectal cystic fibrosis organoids.
Topics: Aminopyridines; Benzodioxoles; Biopsy; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Genotype; Homozygote; Humans; Mutation; Organoids; Protein Folding; Protein Transport; Rectum; Thiazoles; Treatment Outcome | 2016 |
Mechanistic Approaches to Improve Correction of the Most Common Disease-Causing Mutation in Cystic Fibrosis.
Topics: Aminophenols; Aminopyridines; Benzamides; Benzodioxoles; Cell Line; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Endoplasmic Reticulum; Gene Expression Regulation; Half-Life; HEK293 Cells; Humans; Mutation; Quinolones; Thiazoles | 2016 |
Synthesis and electrochemical detection of a thiazolyl-indole natural product isolated from the nosocomial pathogen Pseudomonas aeruginosa.
Topics: Animals; Boron; Carbon; Cattle; Cystic Fibrosis; Diamond; Electrochemical Techniques; Electrodes; Feces; Humans; Indoles; Pseudomonas aeruginosa; Pseudomonas Infections; Thiazoles | 2016 |
Potent s-cis-locked bithiazole correctors of DeltaF508 cystic fibrosis transmembrane conductance regulator cellular processing for cystic fibrosis therapy.
Topics: Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Epithelial Cells; Humans; Models, Chemical; Molecular Structure; Protein Processing, Post-Translational; Stereoisomerism; Thiazoles | 2008 |
Mechanisms for rescue of correctable folding defects in CFTRDelta F508.
Topics: Cell Line; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Endoplasmic Reticulum; Gene Knockdown Techniques; Humans; Protein Conformation; Protein Folding; Protein Stability; Protein Structure, Tertiary; RNA, Small Interfering; Suppression, Genetic; Thiazoles | 2009 |
Design and synthesis of a hybrid potentiator-corrector agonist of the cystic fibrosis mutant protein DeltaF508-CFTR.
Topics: Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Drug Design; Glycine; Humans; Ion Channel Gating; Mutation; Protein Folding; Small Molecule Libraries; Structure-Activity Relationship; Thiazoles | 2010 |
Pyrazolylthiazole as DeltaF508-cystic fibrosis transmembrane conductance regulator correctors with improved hydrophilicity compared to bithiazoles.
Topics: Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Frameshift Mutation; Humans; Pyrazoles; Small Molecule Libraries; Static Electricity; Structure-Activity Relationship; Thiazoles | 2010 |
Dual activity of aminoarylthiazoles on the trafficking and gating defects of the cystic fibrosis transmembrane conductance regulator chloride channel caused by cystic fibrosis mutations.
Topics: Biological Transport; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Humans; Ion Channel Gating; Mutation; Patch-Clamp Techniques; Structure-Activity Relationship; Thiazoles | 2011 |
Increased folding and channel activity of a rare cystic fibrosis mutant with CFTR modulators.
Topics: Benzamides; Cresols; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; HEK293 Cells; Humans; Patch-Clamp Techniques; Protein Folding; Pyrazoles; Thiazoles | 2011 |
Pseudomonas siderophores in the sputum of patients with cystic fibrosis.
Topics: Adult; Cystic Fibrosis; Female; Humans; Iron; Male; Oligopeptides; Phenols; Pseudomonas aeruginosa; Pseudomonas Infections; Siderophores; Sputum; Thiazoles; Young Adult | 2011 |
Rescue of the mutant CFTR chloride channel by pharmacological correctors and low temperature analyzed by gene expression profiling.
Topics: Aminacrine; Bacterial Proteins; Benzamides; Cell Line; Cell Membrane; Chlorides; Ciclopirox; Cold Temperature; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Epithelial Cells; Gene Expression Profiling; Gene Expression Regulation; Humans; Hydroxamic Acids; Luminescent Proteins; Mutation; Piperazines; Protein Transport; Pyridones; Quinazolines; Thiazoles; Vorinostat | 2011 |
Functional fluorescently labeled bithiazole ΔF508-CFTR corrector imaged in whole body slices in mice.
Topics: Animals; Boron Compounds; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Fluorescent Dyes; Mice; Mutation; Thiazoles; Whole Body Imaging | 2011 |
Proteomics of Pseudomonas aeruginosa Australian epidemic strain 1 (AES-1) cultured under conditions mimicking the cystic fibrosis lung reveals increased iron acquisition via the siderophore pyochelin.
Topics: Bacterial Proteins; Bacteriological Techniques; Culture Media; Cystic Fibrosis; Electrophoresis, Gel, Two-Dimensional; Host-Pathogen Interactions; Humans; Iron; Metabolic Networks and Pathways; Phenols; Proteome; Proteomics; Pseudomonas aeruginosa; Pyocyanine; Sputum; Tandem Mass Spectrometry; Thiazoles | 2012 |
Click-based synthesis of triazolobithiazole ΔF508-CFTR correctors for cystic fibrosis.
Topics: Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Dose-Response Relationship, Drug; Molecular Structure; Structure-Activity Relationship; Thiazoles; Triazoles | 2012 |
A novel orally active inhibitor of HLE.
Topics: Administration, Oral; Animals; Asthma; Cyclic S-Oxides; Cystic Fibrosis; Dose-Response Relationship, Drug; Enzyme Inhibitors; Hemorrhage; Humans; Inflammation; Leukocyte Elastase; Lung Diseases, Obstructive; Mice; Models, Chemical; Pulmonary Emphysema; Thiazoles | 2003 |
A small molecule CFTR inhibitor produces cystic fibrosis-like submucosal gland fluid secretions in normal airways.
Topics: Animals; Benzoates; Body Fluids; Bronchi; Cells, Cultured; Chlorides; Cholinergic Agents; Colforsin; Cyclic AMP; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Exocrine Glands; Humans; Hydrogen-Ion Concentration; Pilocarpine; Second Messenger Systems; Sodium; Swine; Thapsigargin; Thiazoles; Thiazolidines; Viscosity | 2004 |
Pseudomonas invasion of type I pneumocytes is dependent on the expression and phosphorylation of caveolin-2.
Topics: Animals; Caveolin 1; Caveolin 2; Caveolins; Cell Adhesion; Cell Line; Cells, Cultured; Coloring Agents; Cystic Fibrosis; Epithelial Cells; Immunoprecipitation; Lipid Metabolism; Lipids; Lung; Membrane Microdomains; Mice; Microscopy, Confocal; Microscopy, Electron; Phosphorylation; Pseudomonas; Pulmonary Alveoli; Rats; Rats, Sprague-Dawley; RNA Interference; Tetrazolium Salts; Thiazoles; Tyrosine | 2005 |
Small-molecule correctors of defective DeltaF508-CFTR cellular processing identified by high-throughput screening.
Topics: Animals; Cells, Cultured; Colforsin; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Drug Design; Enzyme Inhibitors; Epithelial Cells; Genistein; Humans; Iodides; Luminescent Proteins; Molecular Structure; Mutation; Pyrimidinones; Respiratory Mucosa; Thiazoles | 2005 |
Use of stable dye-DNA intercalating complexes to detect cystic fibrosis mutations.
Topics: Alleles; Base Sequence; Cystic Fibrosis; DNA; Fluorescence; Heterozygote; Humans; Mass Screening; Molecular Sequence Data; Mutation; Polymerase Chain Reaction; Protein Binding; Quinolinium Compounds; Thiazoles | 1994 |
Siderophore production by cystic fibrosis isolates of Burkholderia cepacia.
Topics: Burkholderia cepacia; Cystic Fibrosis; Humans; Phenols; Pyridones; Random Amplified Polymorphic DNA Technique; Salicylates; Salicylic Acid; Siderophores; Thiazoles | 1998 |
Siderophore synthesis by mucoid Pseudomonas aeruginosa strains isolated from cystic fibrosis patients.
Topics: Cystic Fibrosis; Iron Chelating Agents; Oligopeptides; Phenols; Pigments, Biological; Pseudomonas aeruginosa; Pseudomonas Infections; Siderophores; Thiazoles | 1991 |
Production and utilization of pyochelin by clinical isolates of Pseudomonas cepacia.
Topics: Cystic Fibrosis; Humans; Iron Chelating Agents; Phenols; Pseudomonas; Pseudomonas Infections; Siderophores; Thiazoles; Transferrin | 1986 |